Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
Journal: Clinical lung cancer
Published: July 31, 2018
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 19, 2017
Assessment of cabozantinib treatment on QT interval in a phase 3 study in medullary thyroid cancer: evaluation of indirect QT effects mediated through treatment-induced changes in serum electrolytes.
Journal: Cancer chemotherapy and pharmacology
Published: May 08, 2017
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: February 13, 2017
Cabozantinib in progressive medullary thyroid cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 05, 2013
Showing 1-5 of 5
Last Updated: 09/26/2026